BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Sadler JE. What's new in the diagnosis and pathophysiology of thrombotic thrombocytopenic purpura. Hematology Am Soc Hematol Educ Program 2015;2015:631-6. [PMID: 26637781 DOI: 10.1182/asheducation-2015.1.631] [Cited by in Crossref: 42] [Cited by in F6Publishing: 36] [Article Influence: 7.0] [Reference Citation Analysis]
Number Citing Articles
1 Sugarman R, Tufano AM, Liu JM. Large vessel stroke as initial presentation of thrombotic thrombocytopenic purpura. BMJ Case Rep 2018;2018:bcr-2017-221857. [PMID: 29437728 DOI: 10.1136/bcr-2017-221857] [Cited by in Crossref: 2] [Article Influence: 0.5] [Reference Citation Analysis]
2 McFarlane PA, Bitzan M, Broome C, Baran D, Garland J, Girard LP, Grewal K, Lapeyraque AL, Patriquin CJ, Pavenski K, Licht C. Making the Correct Diagnosis in Thrombotic Microangiopathy: A Narrative Review. Can J Kidney Health Dis 2021;8:20543581211008707. [PMID: 33996107 DOI: 10.1177/20543581211008707] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
3 Tang N, Wang X, Li D, Sun Z. Validation of the PLASMIC score, a clinical prediction tool for thrombotic thrombocytopenic purpura diagnosis, in Chinese patients. Thrombosis Research 2018;172:9-13. [DOI: 10.1016/j.thromres.2018.10.010] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 2.8] [Reference Citation Analysis]
4 Yap YY, Sathar J, Law KB, Zulkurnain PAB, Edmund SC, Chang KM, Baker R. Clinical characteristics and outcomes of thrombotic microangiopathy in Malaysia. Blood Res 2018;53:130-7. [PMID: 29963519 DOI: 10.5045/br.2018.53.2.130] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
5 Matsumoto M, Fujimura Y, Wada H, Kokame K, Miyakawa Y, Ueda Y, Higasa S, Moriki T, Yagi H, Miyata T, Murata M; For TTP group of Blood Coagulation Abnormalities Research Team, Research on Rare and Intractable Disease supported by Health, Labour, and Welfare Sciences Research Grants. Diagnostic and treatment guidelines for thrombotic thrombocytopenic purpura (TTP) 2017 in Japan. Int J Hematol 2017;106:3-15. [DOI: 10.1007/s12185-017-2264-7] [Cited by in Crossref: 37] [Cited by in F6Publishing: 33] [Article Influence: 7.4] [Reference Citation Analysis]
6 Hrdinová J, D'Angelo S, Graça NAG, Ercig B, Vanhoorelbeke K, Veyradier A, Voorberg J, Coppo P. Dissecting the pathophysiology of immune thrombotic thrombocytopenic purpura: interplay between genes and environmental triggers. Haematologica 2018;103:1099-109. [PMID: 29674502 DOI: 10.3324/haematol.2016.151407] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 4.3] [Reference Citation Analysis]
7 Gödel P, Fischer J, Scheid C, Gathof BS, Wolf J, Rybniker J. Familial acquired thrombotic thrombocytopenic purpura in siblings - no immunogenetic link with associated human leucocyte antigens. Eur J Haematol 2017;98:311-3. [DOI: 10.1111/ejh.12831] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
8 Louw S, Gounden R, Mayne ES. Thrombotic thrombocytopenic purpura (TTP)-like syndrome in the HIV era. Thromb J 2018;16:35. [PMID: 30559606 DOI: 10.1186/s12959-018-0189-x] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
9 Nagalla S, Sarode R. Recent advances in understanding and management of acquired thrombocytopenia. F1000Res 2018;7:68. [PMID: 29399327 DOI: 10.12688/f1000research.12309.1] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
10 Yoshii Y, Fujimura Y, Bennett CL, Isonishi A, Kurumatani N, Matsumoto M. Implementation of a rapid assay of ADAMTS13 activity was associated with improved 30-day survival rate in patients with acquired primary thrombotic thrombocytopenic purpura who received platelet transfusions. Transfusion 2017;57:2045-53. [PMID: 28500622 DOI: 10.1111/trf.14152] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
11 Bandara AGNMK, Matthias AT. Retinal involvement in acute thrombotic thrombocytopenic purpura: a case report. BMC Ophthalmol 2020;20:456. [PMID: 33213410 DOI: 10.1186/s12886-020-01719-z] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
12 Pascual C, Nieto JM, Fidalgo T, Seguí IG, Díaz-Ricart M, Docampo MF, Del Rio J, Salinas R. Multicentric evaluation of the new HemosIL Acustar® chemiluminescence ADAMTS13 activity assay. Int J Lab Hematol 2021;43:485-93. [PMID: 33264480 DOI: 10.1111/ijlh.13414] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
13 Lee C, Huang Y, Li S, Hsu Y, Chen Y, Chen T. Application of PLASMIC Score in Risk Prediction of Thrombotic Thrombocytopenic Purpura: Real-World Experience From a Tertiary Medical Center in Taiwan. Front Med 2022;9:893273. [DOI: 10.3389/fmed.2022.893273] [Reference Citation Analysis]
14 Grall M, Azoulay E, Galicier L, Provôt F, Wynckel A, Poullin P, Grange S, Halimi J, Lautrette A, Delmas Y, Presne C, Hamidou M, Girault S, Pène F, Perez P, Kanouni T, Seguin A, Mousson C, Chauveau D, Ojeda-uribe M, Barbay V, Veyradier A, Coppo P, Benhamou Y. Thrombotic thrombocytopenic purpura misdiagnosed as autoimmune cytopenia: Causes of diagnostic errors and consequence on outcome. Experience of the French thrombotic microangiopathies reference centre: GRALL et al. Am J Hematol 2017;92:381-7. [DOI: 10.1002/ajh.24665] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 3.4] [Reference Citation Analysis]
15 Kucukyurt S, Eskazan AE. Assessment and Monitoring of Patients with Immune-Mediated Thrombotic Thrombocytopenic Purpura (iTTP): Strategies to Improve Outcomes. J Blood Med 2020;11:319-26. [PMID: 33061729 DOI: 10.2147/JBM.S205630] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
16 Dimopoulou D, Dimosiari A, Mandala E, Dimitroulas T, Garyfallos A. Autoimmune Thrombotic Thrombocytopenic Purpura: Two Rare Cases Associated with Juvenile Idiopathic Arthritis and Multiple Sclerosis. Front Med (Lausanne) 2017;4:89. [PMID: 28791286 DOI: 10.3389/fmed.2017.00089] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
17 Joly BS, Coppo P, Veyradier A. An update on pathogenesis and diagnosis of thrombotic thrombocytopenic purpura. Expert Review of Hematology 2019;12:383-95. [DOI: 10.1080/17474086.2019.1611423] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 5.7] [Reference Citation Analysis]
18 Noone DG, Riedl M, Licht C. The role of von Willebrand factor in thrombotic microangiopathy. Pediatr Nephrol 2018;33:1297-307. [DOI: 10.1007/s00467-017-3744-y] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
19 Kayashima M, Sakai K, Harada K, Kanetake J, Kubo M, Hamada E, Hayakawa M, Hatakeyama K, Matsumoto M. Strong association between insufficient plasma exchange and fatal outcomes in Japanese patients with immune-mediated thrombotic thrombocytopenic purpura. Int J Hematol 2021;114:415-23. [PMID: 34292506 DOI: 10.1007/s12185-021-03197-5] [Reference Citation Analysis]
20 Wang HX, Han B, Zhao YY, Kou L, Guo LL, Sun TW, Song LJ. Serum D-dimer as a potential new biomarker for prognosis in patients with thrombotic thrombocytopenic purpura. Medicine (Baltimore) 2020;99:e19563. [PMID: 32221074 DOI: 10.1097/MD.0000000000019563] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
21 Zhou X, Ye X, Ren Y, Mei C, Ma L, Huang J, Xu W, Wei J, Ye L, Mai W, Qian W, Meng H, Jin J, Tong H. Diagnosis and management of acquired thrombotic thrombocytopenic purpura in southeast China: a single center experience of 60 cases. Front Med 2016;10:430-6. [DOI: 10.1007/s11684-016-0492-5] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
22 Joly BS, Coppo P, Veyradier A. Pediatric thrombotic thrombocytopenic purpura. Eur J Haematol 2018;101:425-34. [PMID: 29889319 DOI: 10.1111/ejh.13107] [Cited by in Crossref: 15] [Cited by in F6Publishing: 9] [Article Influence: 3.8] [Reference Citation Analysis]
23 Joly BS, Vanhoorelbeke K, Veyradier A. Understanding therapeutic targets in thrombotic thrombocytopenic purpura. Intensive Care Med 2017;43:1398-400. [PMID: 28116452 DOI: 10.1007/s00134-016-4662-3] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
24 Bugarin-estrada E, Gómez-de León A, López-garcía YK, Díaz-chuc EA, Priesca-marín JM, Ruiz-argüelles GJ, Jaime-pérez JC, Gómez-almaguer D. Clinical presentation in thrombotic thrombocytopenic purpura: Real-world data from two Mexican institutions. J Clin Apher 2018;33:645-53. [DOI: 10.1002/jca.21659] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
25 Prevel R, Roubaud-Baudron C, Tellier E, Le Besnerais M, Kaplanski G, Veyradier A, Benhamou Y, Coppo P; Centre National de Référence des Microangiopathies Thrombotiques. [Endothelial dysfunction in thrombotic thrombocytopenic purpura: therapeutic perspectives]. Rev Med Interne 2021;42:202-9. [PMID: 33455838 DOI: 10.1016/j.revmed.2020.12.011] [Reference Citation Analysis]
26 Xu J, Yu S, Zhang F. Frequent recurrence of pregnancy-triggered congenital thrombotic thrombocytopenic purpura: A rare case report. Clin Hemorheol Microcirc 2021;77:195-200. [PMID: 32925004 DOI: 10.3233/CH-200970] [Cited by in Crossref: 3] [Article Influence: 3.0] [Reference Citation Analysis]
27 Sanchez AP, Balogun RA. Therapeutic Plasma Exchange in the Critically Ill Patient: Technology and Indications. Adv Chronic Kidney Dis 2021;28:59-73. [PMID: 34389138 DOI: 10.1053/j.ackd.2021.03.005] [Reference Citation Analysis]
28 Mariotte E, Azoulay E, Galicier L, Rondeau E, Zouiti F, Boisseau P, Poullin P, de Maistre E, Provôt F, Delmas Y, Perez P, Benhamou Y, Stepanian A, Coppo P, Veyradier A. Epidemiology and pathophysiology of adulthood-onset thrombotic microangiopathy with severe ADAMTS13 deficiency (thrombotic thrombocytopenic purpura): a cross-sectional analysis of the French national registry for thrombotic microangiopathy. The Lancet Haematology 2016;3:e237-45. [DOI: 10.1016/s2352-3026(16)30018-7] [Cited by in Crossref: 113] [Cited by in F6Publishing: 40] [Article Influence: 18.8] [Reference Citation Analysis]
29 Bendapudi PK, Makar RS. An Algorithmic Approach to the Diagnosis and Management of the Thrombotic Microangiopathies. Am J Clin Pathol 2016;145:152-4. [DOI: 10.1093/ajcp/aqw003] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
30 Knoebl P, Cataland S, Peyvandi F, Coppo P, Scully M, Kremer Hovinga JA, Metjian A, de la Rubia J, Pavenski K, Minkue Mi Edou J, De Winter H, Callewaert F. Efficacy and safety of open-label caplacizumab in patients with exacerbations of acquired thrombotic thrombocytopenic purpura in the HERCULES study. J Thromb Haemost 2020;18:479-84. [PMID: 31691462 DOI: 10.1111/jth.14679] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 7.3] [Reference Citation Analysis]
31 Grazioli A, Athale J, Tanaka K, Madathil R, Rabin J, Kaczorowski D, Mazzeffi M. Perioperative Applications of Therapeutic Plasma Exchange in Cardiac Surgery: A Narrative Review. Journal of Cardiothoracic and Vascular Anesthesia 2020;34:3429-43. [DOI: 10.1053/j.jvca.2020.01.054] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
32 Jajosky R, Toscano M, Jajosky A, Savage N. Does Bernard-Soulier syndrome protect against thrombotic thrombocytopenic purpura? J Clin Apher 2018;33:124-5. [PMID: 28653757 DOI: 10.1002/jca.21564] [Reference Citation Analysis]
33 Arab Momeni M, Mostofi A, Jain V, Soni G. COVID19 epidemic outbreak: operating rooms scheduling, specialty teams timetabling and emergency patients' assignment using the robust optimization approach. Ann Oper Res. [DOI: 10.1007/s10479-022-04667-7] [Reference Citation Analysis]
34 Joly BS, Stepanian A, Leblanc T, Hajage D, Chambost H, Harambat J, Fouyssac F, Guigonis V, Leverger G, Ulinski T, Kwon T, Loirat C, Coppo P, Veyradier A; French Reference Center for Thrombotic Microangiopathies. Child-onset and adolescent-onset acquired thrombotic thrombocytopenic purpura with severe ADAMTS13 deficiency: a cohort study of the French national registry for thrombotic microangiopathy. Lancet Haematol. 2016;3:e537-e546. [PMID: 27720178 DOI: 10.1016/s2352-3026(16)30125-9] [Cited by in Crossref: 29] [Cited by in F6Publishing: 11] [Article Influence: 4.8] [Reference Citation Analysis]
35 Cheong HI, Jo SK, Yoon SS, Cho H, Kim JS, Kim YO, Koo JR, Park Y, Park YS, Shin JI, Yoo KH, Oh D. Clinical Practice Guidelines for the Management of Atypical Hemolytic Uremic Syndrome in Korea. J Korean Med Sci 2016;31:1516-28. [PMID: 27550478 DOI: 10.3346/jkms.2016.31.10.1516] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 2.4] [Reference Citation Analysis]
36 Schelpe A, Orlando C, Ercig B, Geeroms C, Pareyn I, Vandeputte N, Velásquez Pereira LC, Roose E, Fostier K, Nicolaes GA, Deckmyn H, De Meyer SF, Vanhoorelbeke K, Jochmans K. Child-onset thrombotic thrombocytopenic purpura caused by p.R498C and p.G259PfsX133 mutations in ADAMTS13. Eur J Haematol 2018;101:191-9. [DOI: 10.1111/ejh.13094] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
37 Favaloro EJ, Mohammed S, Chapman K, Swanepoel P, Zebeljan D, Sefhore O, Malan E, Clifford J, Yuen A, Donikian D, Kondo M, Duncan E, Abraham S, Beggs J, Chatrapati R, Perel J, Coleman R, Klose N, Hsu D, Motum P, Tan CW, Brighton T, Pasalic L. A multicenter laboratory assessment of a new automated chemiluminescent assay for ADAMTS13 activity. J Thromb Haemost 2021;19:417-28. [PMID: 33124748 DOI: 10.1111/jth.15157] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
38 Filatov A, Kassar E, Cole O. Thrombotic Thrombocytopenic Purpura Masquerading as Acute Ischemic Stroke. Cureus 2020;12:e7661. [PMID: 32411562 DOI: 10.7759/cureus.7661] [Reference Citation Analysis]
39 Prevel R, Roubaud-Baudron C, Gourlain S, Jamme M, Peres K, Benhamou Y, Galicier L, Azoulay E, Poullin P, Provôt F, Maury E, Presne C, Hamidou M, Saheb S, Wynckel A, Servais A, Girault S, Delmas Y, Chatelet V, Augusto JF, Mousson C, Perez P, Halimi JM, Kanouni T, Lautrette A, Charvet-Rumpler A, Deligny C, Chauveau D, Veyradier A, Coppo P. Immune thrombotic thrombocytopenic purpura in older patients: prognosis and long-term survival. Blood 2019;134:2209-17. [PMID: 31530564 DOI: 10.1182/blood.2019000748] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 8.0] [Reference Citation Analysis]
40 Browning S, Bahar B, Lee AI, Gorshein E. Spontaneous recovery in a patient with acquired thrombotic thrombocytopenic purpura (TTP): observation of a 'subclinical' TTP state. Hematology 2020;25:473-7. [PMID: 33269995 DOI: 10.1080/16078454.2020.1848973] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]